Cargando…

Correction: Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients

Detalles Bibliográficos
Autores principales:	Wang, Bihua, Zhu, Zhidan, Huang, Feng, Huang, Haowen, Tu, Luxia, Wang, Ying, Zheng, Linfeng, Zhou, Jing, Wei, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513965/ https://www.ncbi.nlm.nih.gov/pubmed/36162983 http://dx.doi.org/10.1186/s12882-022-02950-0

Ejemplares similares

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts outcome of TAC-based treatment for idiopathic membranous nephropathy patients
por: Wang, Bihua, et al.
Publicado: (2022)

Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy
por: Fu, Keying, et al.
Publicado: (2022)

Current concepts on anti-Phospholipase A2 receptor antibody in Idiopathic membranous nephropathy
por: Ardalan, Mohammad Reza
Publicado: (2013)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
por: Ardalan, Mohammad-Reza, et al.
Publicado: (2013)

Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy
por: Jullien, Perrine, et al.
Publicado: (2017)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
por: Guo, Wenkai, et al.
Publicado: (2020)

Ultrasensitive Quantitation of Anti-Phospholipase A2 Receptor Antibody as A Diagnostic and Prognostic Indicator of Idiopathic Membranous Nephropathy
por: Zhang, Qiuhua, et al.
Publicado: (2017)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
por: Lee, Sangho
Publicado: (2018)

Receptor antibody time‐resolved A2 phospholipase bead immunochromatography and its application in idiopathic membranous nephropathy
por: Huang, Biao, et al.
Publicado: (2020)

Role of Anti-Phospholipase A(2) Receptor Antibodies in the Differential Diagnosis of Diabetic and Membranous Nephropathy
por: Pocivalnik, Mirjam, et al.
Publicado: (2013)

Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy
por: Dong, Lei, et al.
Publicado: (2022)

The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy: a single-center retrospective study
por: Li, Chaofan, et al.
Publicado: (2022)

Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018)

Anti-phospholipase A2 Receptor Antibody-Negative Membranous Nephropathy in Pregnancy
por: Saleem, Maryam, et al.
Publicado: (2023)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
por: Xu, Ning-Xin, et al.
Publicado: (2017)

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
por: Porcelli, Brunetta, et al.
Publicado: (2020)

Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China
por: Guo, Naifeng, et al.
Publicado: (2019)

Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy
por: Akiyama, Shin’ichi, et al.
Publicado: (2014)

A comparison of clinical features between idiopathic membranous nephropathy patients with and without serum antibody against phospholipase A2 receptor
por: Zhang, Qiuhua, et al.
Publicado: (2019)

Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study
por: Zhao, Yuchao, et al.
Publicado: (2022)

Phospholipase‐A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy
por: Xiao, Chunying, et al.
Publicado: (2020)

Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics
por: Zhang, Jing, et al.
Publicado: (2020)

Correction to: The elevated levels of urinary angiotensinogen are correlated with the severity of idiopathic membranous nephropathy
por: Tang, Ziyong, et al.
Publicado: (2019)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
por: Li, Chao, et al.
Publicado: (2018)

Coexistence of ANCA-associated glomerulonephritis and anti-phospholipase A(2) receptor antibody-positive membranous nephropathy
por: Surindran, Sheena, et al.
Publicado: (2012)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
por: Song, Eun Joo, et al.
Publicado: (2018)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2020)

Antibody-Guided Therapy in Phospholipase A2 Receptor-Associated Membranous Nephropathy
por: Vink, Coralien H., et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A(2) receptor antibody-positive idiopathic membranous nephropathy: a case report
por: Iio, Rei, et al.
Publicado: (2020)

Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
por: Yin, Peihong, et al.
Publicado: (2020)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
por: Mathew, David, et al.
Publicado: (2021)

Association of anti-phospholipase A(2) receptor antibody with the efficacy of traditional Chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a prospective, cohort clinical study
por: Zhang, Xian-Wen, et al.
Publicado: (2021)

Anti-Phospholipase A2 Receptor in Nonlupus Patients with Membranous Nephropathy and Crescents
por: Zuo, Yiqin, et al.
Publicado: (2021)

Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan
por: Liu, Yu-Huei, et al.
Publicado: (2010)

Role of phospholipase A(2) receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy
por: Mahmud, Maida, et al.
Publicado: (2019)

Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
por: Stefan, Gabriel, et al.
Publicado: (2022)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody
por: Cui, Hao-yuan, et al.
Publicado: (2021)

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis
por: Dong, Dan, et al.
Publicado: (2019)

Author Correction: Detection of urinary podocytes by flow cytometry in idiopathic membranous nephropathy
por: Mella, Alberto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1miiuub8jou21ktp235jb5vn15